Hongjie Pan

Hongjie Pan currently serves as the Director of Antibody Discovery at Leveragen, leading a team focused on antibody characterization and immunization strategies since February 2023. Previously, Hongjie Pan held the position of Director at HARBOUR BIOMED, overseeing multiple projects from discovery to preclinic, and undertaking bispecific antibody design. Other roles include Senior Principal Scientist and Principal Scientist, contributing to antibody discovery and engineering efforts. Earlier experience includes a role as Scientist II at Abpro and research positions at Duke University, Boston University School of Medicine, and Dana-Farber Cancer Institute. Hongjie Pan earned a PhD in Pathology from The University of Georgia, complemented by advanced degrees in Microbiology, Immunology, and Veterinary Medicine from Nanjing Agricultural University and Anhui Agricultural University.